{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T11:34:17Z","timestamp":1648812857374},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T00:00:00Z","timestamp":1387324800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00404-013-3120-5","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T14:25:36Z","timestamp":1387290336000},"page":"1281-1286","source":"Crossref","is-referenced-by-count":2,"title":["Detection of E6-AP as a potential therapeutic target in cervical specimen of HPV-infected women"],"prefix":"10.1007","volume":"289","author":[{"given":"Peter","family":"Hillemanns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Jentschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Soergel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Hass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,18]]},"reference":[{"key":"3120_CR1","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","volume":"337","author":"M Arbyn","year":"2008","unstructured":"Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P et al (2008) Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ(Clinical research ed) 337:a1284","journal-title":"BMJ(Clinical research ed)"},{"issue":"2","key":"3120_CR2","doi-asserted-by":"crossref","first-page":"169e1","DOI":"10.1016\/j.ajog.2010.09.020","volume":"204","author":"JL Brun","year":"2011","unstructured":"Brun JL, Dalstein V, Leveque J, Mathevet P, Raulic P, Baldauf JJ et al (2011) Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy. Am J Obstet Gynecol 204(2):169e1\u2013169e8","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"3120_CR3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ygyno.2007.04.038","volume":"106","author":"MH Einstein","year":"2007","unstructured":"Einstein MH, Kadish AS, Burk RD, Kim MY, Wadler S, Streicher H et al (2007) Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III. Gynecol Oncol 106(3):453\u2013460","journal-title":"Gynecol Oncol"},{"issue":"1","key":"3120_CR4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2008.01.008","volume":"109","author":"JL Young","year":"2008","unstructured":"Young JL, Jazaeri AA, Darus CJ, Modesitt SC (2008) Cyclooxygenase-2 in cervical neoplasia: a review. Gynecol Oncol 109(1):140\u2013145","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3120_CR5","doi-asserted-by":"crossref","first-page":"300e1","DOI":"10.1016\/j.ajog.2007.07.045","volume":"198","author":"P Hillemanns","year":"2008","unstructured":"Hillemanns P, Wang X, Hertel H, Andikyan V, Hillemanns M, Stepp H et al (2008) Pharmacokinetics and selectivity of porphyrin synthesis after topical application of hexaminolevulinate in patients with cervical intraepithelial neoplasia. Am J Obstet Gynecol 198(3):300e1\u2013300e7","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"3120_CR6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"zur H Hausen","year":"2002","unstructured":"Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2(5):342\u2013350","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"3120_CR7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","volume":"103","author":"M Schiffman","year":"2011","unstructured":"Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE (2011) Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103(5):368\u2013383","journal-title":"J Natl Cancer Inst"},{"key":"3120_CR8","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1002\/j.1460-2075.1989.tb08570.x","volume":"8","author":"P Hawley-Nelson","year":"1989","unstructured":"Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT (1989) HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8:3905\u20133910","journal-title":"EMBO J"},{"key":"3120_CR9","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1128\/JVI.63.10.4417-4421.1989","volume":"63","author":"K Munger","year":"1989","unstructured":"Munger K, Phelps WC, Bubb V, Howley PH, Schlegel R (1989) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63:4417\u20134421","journal-title":"J Virol"},{"issue":"1","key":"3120_CR10","first-page":"63","volume":"62","author":"O Peralta-Zaragoza","year":"2010","unstructured":"Peralta-Zaragoza O, Bermudez-Morales VH, Madrid-Marina V (2010) RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer. Rev Invest Clin 62(1):63\u201380","journal-title":"Rev Invest Clin"},{"issue":"5","key":"3120_CR11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2230.2009.03624.x","volume":"35","author":"XZ Chen","year":"2010","unstructured":"Chen XZ, Zhu KJ, Xu Y, Tang XY, Cai XZ, Zhang X et al (2010) RNA interference silences the human papillomavirus 6b\/11 early gene E7 in vitro and in vivo. Clin Exp Dermatol 35(5):509\u2013515","journal-title":"Clin Exp Dermatol"},{"issue":"14","key":"3120_CR12","doi-asserted-by":"crossref","first-page":"9296","DOI":"10.1128\/JVI.79.14.9296-9300.2005","volume":"79","author":"A Hengstermann","year":"2005","unstructured":"Hengstermann A, D\u2019Silva MA, Kuballa P, Butz K, Hoppe-Seyler F, Scheffner M (2005) Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53. J Virol 79(14):9296\u20139300","journal-title":"J Virol"},{"issue":"1","key":"3120_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.virol.2009.07.029","volume":"393","author":"V Tomaic","year":"2009","unstructured":"Tomaic V, Pim D, Banks L (2009) The stability of the human papillomavirus E6 oncoprotein is E6AP dependent. Virology 393(1):7\u201310","journal-title":"Virology"},{"issue":"12","key":"3120_CR14","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/0008-5472.CAN-09-3307","volume":"70","author":"A Shai","year":"2010","unstructured":"Shai A, Pitot HC, Lambert PF (2010) E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice. Cancer Res 70(12):5064\u20135073","journal-title":"Cancer Res"},{"issue":"7","key":"3120_CR15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrd837","volume":"1","author":"JB Opalinska","year":"2002","unstructured":"Opalinska JB, Gewirtz AM (2002) Nucleic-acid therapeutics: basic principles and recent applications. Nat Rev Drug Discov 1(7):503\u2013514","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"3120_CR16","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0002-9440(10)63267-1","volume":"165","author":"B Kim","year":"2004","unstructured":"Kim B, Tang Q, Biswas PS, Xu J, Schiffelers RM, Xie FY et al (2004) Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol 165(6):2177\u20132185","journal-title":"Am J Pathol"},{"issue":"2","key":"3120_CR17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00535-009-0132-9","volume":"45","author":"T Mizui","year":"2010","unstructured":"Mizui T, Yamashina S, Tanida I, Takei Y, Ueno T, Sakamoto N et al (2010) Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy. J Gastroenterol 45(2):195\u2013203","journal-title":"J Gastroenterol"},{"issue":"2","key":"3120_CR18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ygyno.2008.06.033","volume":"111","author":"AL Jonson","year":"2008","unstructured":"Jonson AL, Rogers LM, Ramakrishnan S, Downs LS Jr (2008) Gene silencing with siRNA targeting E6\/E7 as a therapeutic intervention in a mouse model of cervical cancer. Gynecol Oncol 111(2):356\u2013364","journal-title":"Gynecol Oncol"},{"issue":"8","key":"3120_CR19","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/ijc.26197","volume":"130","author":"HS Jung","year":"2011","unstructured":"Jung HS, Erkin OC, Kwon MJ, Kim SH, Jung JI, Oh YK et al (2011) The synergistic therapeutic effect of cisplatin with Human papillomavirus E6\/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo. Int J Cancer 130(8):1925\u20131936","journal-title":"Int J Cancer"},{"issue":"8","key":"3120_CR20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/cgt.2011.28","volume":"18","author":"K Yamato","year":"2011","unstructured":"Yamato K, Egawa N, Endo S, Ui-Tei K, Yamada T, Saigo K et al (2011) Enhanced specificity of HPV16 E6E7 siRNA by RNA-DNA chimera modification. Cancer Gene Ther 18(8):587\u2013597","journal-title":"Cancer Gene Ther"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-013-3120-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-013-3120-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-013-3120-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T07:52:12Z","timestamp":1597218732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-013-3120-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,18]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["3120"],"URL":"https:\/\/doi.org\/10.1007\/s00404-013-3120-5","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,18]]}}}